Empagliflozin

Initially developed as a diabetes medication, empagliflozin works by causing the kidneys to remove excess blood sugar through urine. However, extensive clinical evidence revealed that it also provides powerful protection for the heart and kidneys, two organs highly susceptible to age-related decline. This has prompted its emerging use for healthspan optimization, as its broader metabolic effects—including lowered blood pressure and a mild state of ketosis—help shield these key organ systems from the damage that drives age-related disease.

Verdict

A powerful tool for cardio-renal protection, but requires medical supervision.

Protocol

• Standard clinical doses are 10 mg or 25 mg taken once daily in the morning.
• Off-label healthspan use often mirrors the lower clinical dose of 10 mg daily.

Flags

• Increased risk of urinary tract and genital yeast infections is a common side effect.
• Can cause dehydration and low blood pressure; adequate hydration is crucial.
• Carries a rare but serious risk of euglycemic ketoacidosis (eDKA), even with normal glucose levels.
• Requires periodic monitoring of kidney function (eGFR).
• A rare but severe genital infection (Fournier's gangrene) is a class-wide warning.